Sanofi and GlaxoSmithKline are working together on a vaccine that they hope to get approved in the first half of next year. Bloomberg
Sanofi and GlaxoSmithKline are working together on a vaccine that they hope to get approved in the first half of next year. Bloomberg

Economy

Sanofi and GSK hoping to price Covid-19 vaccine at under €10

The pair said last week that they hoped a protein-based vaccine would be in phase III trials by December

Reuters

September 06, 2020